Compare Cytokinetics Inc (CYTK) vs Dolby Laboratories, Inc. (DLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Dolby Laboratories, Inc. — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B). The key difference: Cytokinetics Inc is the larger of the two by market cap, and Dolby Laboratories, Inc. pays a 2.35% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | DLB | |
|---|---|---|
Market Cap | $10.63B | $5.75B |
Sector | Technology | Industrials |
52-Week High | $87.26 | $75.62 |
52-Week Low | $34.31 | $48.51 |
Enterprise Value | $10.74B | $5.12B |
Dividend Yield | — | 2.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →
